News

This is the first application of Intravail in a solid dosage form. The Intravail formulation is compatible with current tableting processes employed for OTC and prescription drugs and

Burman’s knew that when these drugs hit the market, they were going to require intensive management in order to reach their potential for eliminating HCV in most patients.

ChromaDex will provide GBB with quantities of its proprietary NIAGEN nicotinamide riboside (NR) ingredient. NIAGEN is the first and only commercially available form of NR, a naturally-occurring vitamin

With this contract award ClinicalRM becomes part of a clinical studies network being established by BARDA to support development of vaccines, drugs, and diagnostics, known as medical countermeasures,

Under the agreement, Zubsolv will be given preferred, Tier 2 brand status on UHG commercial employer and individual formularies managed by OptumRx for the maintenance treatment of opioid

The trial, which evaluated the efficacy of two dose regimens of mepolizumab, also met its primary endpoint of reduction in the frequency of exacerbations. Throughout the trial, patients

ND0612 is being developed for continuous subcutaneous administration through a patch pump and is designed to provide steady levodopa blood levels for the treatment of PD. The company

Under the deal, Medinet will license its new cell therapy technology to TC Biopharm for clinical development in the UK and Europe. The deal and subsequent commercialization is

UCB’s research arm UCB NewMedicines has used a new approach to identify small molecules modulators of a biological pathway, for which parenterally administered biologic therapies have proven highly